HighTower Advisors’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-560
Closed -$5K 3470
2022
Q2
$5K Buy
560
+549
+4,991% +$27K ﹤0.01% 3126
2022
Q1
$14K Buy
+11
New +$549 ﹤0.01% 3199

Other funds holding AXLA

HighTower Advisors's AXLA Position: Q3 2022 in Review

HighTower Advisors sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2022, closing a stake of 440 shares — an estimated $22K sold.

HighTower Advisors first reported a position in AXLA in Q3 2020 and held it in 8 quarters. The position peaked at $52K in Q4 2020. 32 funds tracked by Wall St. Rank hold AXLA as of Q3 2022.

  • HighTower Advisors reported no remaining Axcella Health Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 440 Axcella Health Inc. Common Stock shares in Q3 2022, an estimated $22K.
  • HighTower Advisors first reported a position in Axcella Health Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • HighTower Advisors's Axcella Health Inc. Common Stock position peaked at $52K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.